Search
Displaying 401–410 of 526 for “Retinitis pigmentosa”
-
Foundation News
The program will offer patients with inherited retinal disease no-cost genetic testing and genetic counseling in the United States. Look for updated information on how to participate to be posted in mid-October, with program registration starting shortly thereafter.
-
Foundation News
Three-day conference in San Diego will feature retinal science’s leading researchers and clinicians, and focus on the year’s top science and emerging treatments
-
Foundation News
The free, online event on March 20, 2024, will feature presentations from Rachel Huckfeldt, MD, PhD, Mass Eye and Ear, and Rachelle Lin, OD, Ketchum University.
-
Foundation News
The May 11th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Foundation News
Uni-Rare Study will improve clinical understanding of more IRDs and boost development of potential therapies.
-
My name is Christy Johnson, I have Retinitis Pigmentosa, a degenerative, progressive disease that will eventually rob me of my sight. Having been diagnosed only 2 years ago, I learned that I now have 38 degrees of periphery, suffer from severe night blindness, and I am having difficulty being able to see certain colors.
-
Foundation News
Initiatives to increase engagement and awareness around blinding retinal diseases.
-
Foundation Fighting Blindness Makes Key Appointments to Leadership Team
Foundation NewsSeveral executives promoted to continue the advancement of the Foundation’s notable research and philanthropic efforts.
-
Foundation Fighting Blindness Announces Leadership Changes
Foundation NewsJason Menzo named chief executive officer • Russell Kelley, PhD, MBA, appointed managing director of the RD Fund • Ben Yerxa, PhD, to lead Opus Genetics, the first RD Fund- and Foundation-backed spin-off company.
-
Foundation Fighting Blindness to Host VISIONS 2022 Conference
Foundation NewsThe national conference will be held on June 17–18, featuring sessions with the latest research advancements, practical adapting and thriving, and an opportunity to connect with the blind and low vision community.
